Product Information
Pomalidomide-PEG1-N3 is a unique compound that combines the therapeutic benefits of pomalidomide with the versatility of PEGylation. Pomalidomide is a potent immunomodulatory drug that has been used in the treatment of multiple myeloma and other hematological malignancies. PEGylation, on the other hand, involves attaching polyethylene glycol (PEG) molecules to a drug or therapeutic agent to enhance its stability, bioavailability, and therapeutic efficacy.
With Pomalidomide-PEG1-N3, you get the best of both worlds. The PEGylation process allows for controlled release and prolonged circulation time in the body, ensuring optimal drug delivery and maximum therapeutic effect. The azide PEG linker used in this compound provides stability and flexibility while maintaining its pharmacological activity.
This innovative compound offers numerous advantages over traditional formulations. The PEGylation of pomalidomide not only improves its solubility but also reduces its
Chemical properties
Technical inquiry about: 3D-IKD36004 Pomalidomid- PEG1-N3
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
